Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

RPS Scotland expects all patient-facing pharmacists to be independent prescribers by 2030

The Royal Pharmaceutical Society (RPS) in Scotland expects all pharmacists in a patient-facing role to become independent prescribers by 2030.

In a report published on Wednesday (February 2), the RPS outlined the vision for pharmacy in 2030, forecasting the “traditional boundaries between pharmacy sectors will be broken down” by then.


It said that by 2030, pharmacy teams will work together, using their expertise and making the best use of medicine to deliver “seamless care for patients.”

Clare Morrison, director for Scotland at RPS, said: “In our vision, pharmacists will be recognised as medicines experts who take leadership of prescribing in all care settings and optimise therapeutic outcomes for patients. This means prescribing, monitoring, reviewing, adjusting and stopping medicines, underpinned by empowering patients to make shared decisions.”

The report, jointly published by RPS Scotland and the National Pharmacy Technician Group Scotland (NPTGS), covers the vision co-produced with pharmacists and pharmacy technicians working in all healthcare settings across Scotland, including community pharmacy, hospitals and GP practices.

Melanie Bryan, chair of NPTGS, said: “The vision sets out that in 2030, pharmacy technicians will lead medicines management processes, both in technical roles focused on safe and efficient supply of medicines, and in patient-focused roles to support patients’ use of medicines.”

The vision describes that having the right skill mix in pharmacy teams through robust workforce planning will be crucial for both increasing capacity of teams and improving patient care.

RPS will use the vision to communicate with partners across NHS, Scottish government and Holyrood about initiatives that are needed to maximise the potential of pharmacy across the health and social care system.

Besides, RPS has called for the introduction of a single shared electronic patient record across all health and care services, which would release clinicians’ capacity, improve safety and ensure better care for patients.

Commenting on the report, Andrew Carruthers, chair of the Scottish Pharmacy Board, said: “Pharmacy teams already make a huge contribution to people every day, and a spotlight was shone on their vital work during the pandemic. However, we also know that pharmacy has the potential to achieve so much more, and publishing Pharmacy 2030 is the first step on our journey to achieving this.

“By working with partners across health and social care, we will ensure pharmacy continues to deliver improved health outcomes for people, across all care settings, long into the future.”

More For You

Home cervical screening kits in England

Government data states that around five million women are still not attending cervical screenings

Getty Images

Home cervical screening kits launched in England

Key Summary

  • NHS England has launched at-home cervical screening kits to improve uptake among women aged 25 to 64.
  • The discreet kits aim to overcome barriers like embarrassment and increase screening rates from 68.8 per cent towards the 80 per cent target.
  • Early diagnosis through home testing is expected to boost survival rates and help tackle cervical cancer for all communities.

NHS England has created an innovative at-home human papillomavirus (HPV) testing, for women who are yet to take cervical screening service.

Keep ReadingShow less
NHS warns doctors using unapproved  AI Software

NHS England has demanded that GPs and hospitals stop using artificial intelligence software that could breach data protection rules.

iStock

NHS warns doctors against use of unapproved AI software

Key Summary

  • NHS wants GPs and hospitals to stop using dubious artificial intelligence software during patient meetings
  • It had in April urged the doctors to use AI for notetaking using Ambient Voice Technology software
  • But it now claims that many AVT suppliers, who fail to meet NHS governance standards, are selling them to doctors
  • British Medical Association officials want the NHS to help doctors choose the safe AVT software

Doctors have been warned against the use of AI software that does not meet minimum standards to record and transcribe patient meetings.

Keep ReadingShow less
Mother holding newborn baby during early postnatal care in NHS maternity setting

Mother with newborn in NHS maternity care

Getty Images

Failing maternity services leads to nation-wide inquiry

Key Summary
  • Wes Streeting has ordered a national inquiry into failing NHS maternity and neonatal services
  • The review will start this summer, focusing first on the worst-performing units
  • A second phase will examine the entire system and propose national improvements
  • The inquiry will tackle racial inequalities and maternity mortality disparities

Health Secretary Wes Streeting has commissioned a nation-wide inquiry due to the rise in the number of failing maternity and neonatal services in the country.

NHS trusts such as Morecambe Bay, Shrewsbury and Telford, East Kent, Nottingham and Leeds are some of the names on the worst-performing list.

Keep ReadingShow less
UK globally competitive in life sciences

The Industrial Strategy has identified eight high-growth potential sectors, including life sciences.

iStock

Key test will be to make UK globally competitive in life sciences: ABPI

Key Summary

  • The Industrial Strategy has identified life sciences as one of its high-growth potential sectors
  • ABPI wants the UK to become a leading centre for life sciences research and development
  • It wants the government to move quickly from planning to delivery

The Association of the British Pharmaceutical Industry (ABPI) has welcomed the government’s new Industrial Strategy, but said the key test for life sciences will be whether it can return the UK to international competitiveness.

Keep ReadingShow less
Screening newborn babies for rare diseases will involve sequencing their complete DNA

Screening newborn babies for rare diseases will involve sequencing their complete DNA

iStock

DNA test for all babies to study disease risk

Key Summary

  • The DNA of newborn babies will be sequenced using blood samples from their umbilical cord
  • The government will invest £650m in DNA research for all patients by 2030
  • Genomics and AI would be used for faster diagnoses

Children born in England will have their DNA mapped to screen for hundreds of diseases under the NHS plan for the next 10 years.

Keep ReadingShow less